Curtis, Jeffrey R <br/><br/>
Reanalysis of the Multi-Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic-Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al.  [electronic resource] 

 -  Arthritis & rheumatology (Hoboken, N.J.)  04 2017 
 - 863-865 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>2326-5205 
<br/><br/><label>Standard No.: </label>10.1002/art.39981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Adalimumab<br/>Antirheumatic Agents<br/>Arthritis, Rheumatoid<br/>Biological Products<br/>Biomarkers<br/>Humans<br/>Methotrexate